Evotec SE (ETR:EVT - Get Free Report) shares shot up 2.2% during trading on Tuesday . The company traded as high as €6.00 ($7.06) and last traded at €5.95 ($7.00). 505,120 shares changed hands during trading, a decline of 63% from the average session volume of 1,360,000 shares. The stock had previously closed at €5.82 ($6.84).
Evotec Price Performance
The stock has a market cap of $1.16 billion, a P/E ratio of -6.78, a PEG ratio of 0.98 and a beta of 1.05. The business's 50 day simple moving average is €6.45 and its 200 day simple moving average is €6.67.
Evotec Company Profile
(
Get Free Report)
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Read More
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
